Skip to content
OpenCapital
Get started

Theriva Biologics TOVX Q3 2025 earnings

Reported November 12, 2025 · Before market open

EPS-$0.45Miss by $0.07
EPS estimate-$0.38

Next report

Aug 12, 2026 (In 1 week)
Revenue estimate$300.0K
EPS estimate-$0.06

Versus estimates

Revenue

Q1 2026$300.0KIn lineQ4 2024$154.0K

Diluted EPS

Q1 2026-$0.05In lineQ4 2025$1.85Beat by $2.29
Q3 2025-$0.45Miss by $0.07
Q2 2025-$1.93Miss by $1.55Q1 2025-$1.55Beat by $2.64Q4 2024-$3.30Beat by $3.06

Ask the moment Theriva Biologics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Theriva Biologics report Q3 2025 earnings?
Theriva Biologics (TOVX) reported Q3 2025 earnings on November 12, 2025 before market open.
What were Theriva Biologics's Q3 2025 revenue and EPS?
Theriva Biologics reported eps of $-0.45 for Q3 2025.
Did Theriva Biologics beat estimates in Q3 2025?
EPS missed the consensus estimate of $-0.38 by $0.07.
How did Theriva Biologics's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 93.4% from $-6.81.
Where can I find Theriva Biologics's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001104659-25-109821) and the 10-Q periodic report (0001104659-25-109828) directly on SEC EDGAR. The filing index links above go to sec.gov.